WO2010077867A3 - Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus - Google Patents
Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus Download PDFInfo
- Publication number
- WO2010077867A3 WO2010077867A3 PCT/US2009/068062 US2009068062W WO2010077867A3 WO 2010077867 A3 WO2010077867 A3 WO 2010077867A3 US 2009068062 W US2009068062 W US 2009068062W WO 2010077867 A3 WO2010077867 A3 WO 2010077867A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extracts
- compositions
- astragalus membranaceus
- thrombocytopenic purpura
- idiopathic thrombocytopenic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/196—Thrombopoietin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/202—IL-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011540971A JP5732604B2 (en) | 2008-12-15 | 2009-12-15 | Treatment of idiopathic thrombocytopenic purpura with a composition containing Echinacea extract |
SG2011041787A SG172029A1 (en) | 2008-12-15 | 2009-12-15 | Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus |
CN200980155742.9A CN102300576B (en) | 2008-12-15 | 2009-12-15 | Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus |
EP09836839.2A EP2376096B1 (en) | 2008-12-15 | 2009-12-15 | Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus |
KR1020117016274A KR101780074B1 (en) | 2008-12-15 | 2009-12-15 | Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12258608P | 2008-12-15 | 2008-12-15 | |
US61/122,586 | 2008-12-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010077867A2 WO2010077867A2 (en) | 2010-07-08 |
WO2010077867A3 true WO2010077867A3 (en) | 2010-11-25 |
Family
ID=42266446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/068062 WO2010077867A2 (en) | 2008-12-15 | 2009-12-15 | Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus |
Country Status (9)
Country | Link |
---|---|
US (2) | US8137710B2 (en) |
EP (1) | EP2376096B1 (en) |
JP (1) | JP5732604B2 (en) |
KR (1) | KR101780074B1 (en) |
CN (1) | CN102300576B (en) |
MY (1) | MY159317A (en) |
SG (1) | SG172029A1 (en) |
TW (1) | TWI507201B (en) |
WO (1) | WO2010077867A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103142726A (en) * | 2013-02-21 | 2013-06-12 | 上海浦东高星生物技术研究所 | Ulcer hemorrhage stopping powder |
WO2016028714A1 (en) * | 2014-08-18 | 2016-02-25 | Pharmagenesis, Inc. | Polygalacturonan rhamnogalacturonan1 (pgrg1) composition |
CN104173563A (en) * | 2014-08-22 | 2014-12-03 | 上海中医药大学附属岳阳中西医结合医院 | Traditional Chinese medicine composition for treating idiopathic thrombocytopenic purpura |
CN104740405B (en) * | 2015-04-14 | 2018-09-04 | 日照市中医医院 | A kind of Chinese medicine preparation and preparation method for treating anaphylactoid purpura renal damage |
CN104784419A (en) * | 2015-04-24 | 2015-07-22 | 陕西郝其军制药股份有限公司 | Traditional Chinese medicine composition for treating immune thrombocytopenic purpura and preparation method of traditional Chinese medicine composition |
CN108066354A (en) * | 2016-11-10 | 2018-05-25 | 怀特生技新药股份有限公司 | Purposes of the astragalus polyose extract in the drug for enhancing immunotherapy for cancer effect is prepared |
CN109199907A (en) * | 2017-07-07 | 2019-01-15 | 怀特生技新药股份有限公司 | Radix Astragali extract is preparing the application in the composition for inhibiting melanin production |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100195884B1 (en) * | 1996-02-12 | 1999-06-15 | 김박광 | Blood glucose lowering composition containing extract of astragali radix and process for preparing extract of astragali radix |
KR20020089817A (en) * | 2001-05-24 | 2002-11-30 | 한국원자력연구소 | Extract of herb mixture for heamatopoiesis augmentation and protection from radiation |
KR20030091921A (en) * | 2003-11-17 | 2003-12-03 | 한국원자력연구소 | Extract of herb mixture for heamatopoiesis augmentation and protection from radiation |
KR100526404B1 (en) * | 2003-07-31 | 2005-11-08 | 학교법인 한림대학교 | Composition for preventing neuronal cell death caused by cerebral ischemia continiaing extract from astragali radix root |
KR100697212B1 (en) * | 2005-01-29 | 2007-03-22 | 서울향료(주) | Hematopoietic enhancer comprising herbal mixture extract of Astragali Radix and Angelicae Gigantis Radix for treating side-effect caused by administrating anticancer agent |
KR100760384B1 (en) * | 2006-02-22 | 2007-09-19 | 경희대학교 산학협력단 | Composition comprising the extract of Astragalus membranaceus BGE. showing angiogenesis promoting activity and bone healing activity for preventing and treating fracture |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4795742A (en) * | 1985-09-24 | 1989-01-03 | Yaguang Liu | Therapeutic composition from plant extracts |
US4708949A (en) * | 1985-09-24 | 1987-11-24 | Yaguang Liu | Therapeutic composition from plant extracts |
US5554386A (en) * | 1986-07-03 | 1996-09-10 | Advanced Magnetics, Inc. | Delivery of therapeutic agents to receptors using polysaccharides |
US5589591A (en) * | 1986-07-03 | 1996-12-31 | Advanced Magnetics, Inc. | Endotoxin-free polysaccharides |
US5478576A (en) * | 1986-07-03 | 1995-12-26 | Advanced Magnetics, Inc. | Arabinogalactan derivatives and uses thereof |
US5336506A (en) * | 1986-07-03 | 1994-08-09 | Advanced Magnetics Inc. | Targeting of therapeutic agents using polysaccharides |
US5679323A (en) * | 1986-07-03 | 1997-10-21 | Advanced Magnetics, Inc. | Hepatocyte-specific receptor-mediated endocytosis-type compositions |
US4843067A (en) * | 1986-11-19 | 1989-06-27 | Yaguang Liu | Polysaccharide containing pharmaceutical composition for increasing the immune function |
US4944946A (en) * | 1987-01-27 | 1990-07-31 | Yaguang Liu | Pharmaceutical composition for inhibiting viruses and increasing immune function (PII) |
US5268467A (en) * | 1988-05-23 | 1993-12-07 | Verbiscar Anthony J | Immunomodulatory polysaccharide fractions from Astragalus plants |
CN1027168C (en) | 1989-05-13 | 1994-12-28 | 储大同 | Bioregulator made from Inter leukin-2 |
US4950751A (en) * | 1989-06-02 | 1990-08-21 | The Nanci Corporation International | Method of isolating arabinogalactan from larch |
IT1238685B (en) | 1990-02-09 | 1993-09-01 | Indena Spa | IMMUNOMODULATING ACTION POLYSACCHARIDES FROM ASTRAGALUS MEMBRANACEOUS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM |
US5116969B1 (en) * | 1990-04-26 | 1997-04-01 | Larex International Inc | Ultrarefined arabinogalactan product |
CN1025590C (en) | 1990-07-20 | 1994-08-10 | 邓恺 | Preparation of injection for anal fistula |
ES2049561B1 (en) | 1991-04-27 | 1994-12-16 | Andromaco Lab | PROCEDURE FOR OBTAINING POLYMERS WITH ACTIVITY ON THE HEMATOPOYETIC SYSTEM. |
US5547997A (en) | 1991-10-01 | 1996-08-20 | Chemisches Laboratorium Dr. Kurt Richter Gmbh | Plant-derived cosmetic composition and method of treatment of skin |
US5646029A (en) * | 1993-12-03 | 1997-07-08 | Cooperative Research Centre For Industrial Plant Biopolymers | Plant arabinogalactan protein (AGP) genes |
US5756098A (en) * | 1995-12-12 | 1998-05-26 | The University Of Montana | Methods for the extraction of phytochemicals from fibrous plants in the absence of solvent |
US5770217A (en) * | 1997-07-02 | 1998-06-23 | Atlatl, Inc. | Dietary supplement for hematological, immune and appetite enhancement |
CN1179979C (en) * | 1999-06-30 | 2004-12-15 | 法蒙金希公司 | Hematopoietic arabinogalactan composition |
JP2004502703A (en) * | 2000-06-29 | 2004-01-29 | ファーマジェネシス, インコーポレイテッド | Acid-modified arabinogalactan protein composition |
JP2006070217A (en) * | 2004-09-03 | 2006-03-16 | Kitasato Inst:The | Polysaccharide and biophylactic activation agent originated from aboveground part of astragalus mongholicus bunge |
-
2009
- 2009-12-15 TW TW098143056A patent/TWI507201B/en active
- 2009-12-15 CN CN200980155742.9A patent/CN102300576B/en active Active
- 2009-12-15 EP EP09836839.2A patent/EP2376096B1/en active Active
- 2009-12-15 KR KR1020117016274A patent/KR101780074B1/en active IP Right Grant
- 2009-12-15 JP JP2011540971A patent/JP5732604B2/en active Active
- 2009-12-15 WO PCT/US2009/068062 patent/WO2010077867A2/en active Application Filing
- 2009-12-15 SG SG2011041787A patent/SG172029A1/en unknown
- 2009-12-15 US US12/638,845 patent/US8137710B2/en active Active
- 2009-12-15 MY MYPI2011002701A patent/MY159317A/en unknown
-
2012
- 2012-02-07 US US13/368,319 patent/US8728543B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100195884B1 (en) * | 1996-02-12 | 1999-06-15 | 김박광 | Blood glucose lowering composition containing extract of astragali radix and process for preparing extract of astragali radix |
KR20020089817A (en) * | 2001-05-24 | 2002-11-30 | 한국원자력연구소 | Extract of herb mixture for heamatopoiesis augmentation and protection from radiation |
KR100526404B1 (en) * | 2003-07-31 | 2005-11-08 | 학교법인 한림대학교 | Composition for preventing neuronal cell death caused by cerebral ischemia continiaing extract from astragali radix root |
KR20030091921A (en) * | 2003-11-17 | 2003-12-03 | 한국원자력연구소 | Extract of herb mixture for heamatopoiesis augmentation and protection from radiation |
KR100697212B1 (en) * | 2005-01-29 | 2007-03-22 | 서울향료(주) | Hematopoietic enhancer comprising herbal mixture extract of Astragali Radix and Angelicae Gigantis Radix for treating side-effect caused by administrating anticancer agent |
KR100760384B1 (en) * | 2006-02-22 | 2007-09-19 | 경희대학교 산학협력단 | Composition comprising the extract of Astragalus membranaceus BGE. showing angiogenesis promoting activity and bone healing activity for preventing and treating fracture |
Also Published As
Publication number | Publication date |
---|---|
JP2012512176A (en) | 2012-05-31 |
SG172029A1 (en) | 2011-07-28 |
CN102300576A (en) | 2011-12-28 |
US20100158861A1 (en) | 2010-06-24 |
EP2376096A2 (en) | 2011-10-19 |
US8137710B2 (en) | 2012-03-20 |
KR101780074B1 (en) | 2017-09-19 |
KR20110094343A (en) | 2011-08-23 |
EP2376096A4 (en) | 2013-10-02 |
CN102300576B (en) | 2014-03-05 |
TWI507201B (en) | 2015-11-11 |
WO2010077867A2 (en) | 2010-07-08 |
TW201026318A (en) | 2010-07-16 |
EP2376096B1 (en) | 2019-07-24 |
JP5732604B2 (en) | 2015-06-10 |
US8728543B2 (en) | 2014-05-20 |
MY159317A (en) | 2016-12-30 |
US20120141412A1 (en) | 2012-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010077867A3 (en) | Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus | |
WO2008030567A3 (en) | Dry powder compound formulations and uses thereof | |
WO2013122932A3 (en) | Topical use of a skin-commensal prebiotic agent and compositions containing the same | |
WO2007113222A3 (en) | Immunogenic composition | |
NZ600118A (en) | Lipopeptide compositions and related methods | |
WO2008036932A3 (en) | Compositions and methods comprising boswellia species | |
WO2009109927A3 (en) | Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer | |
WO2007127273A3 (en) | Methods and compositions for altering cell function | |
WO2009007328A3 (en) | Use of homo- and copolymers for stabilizing active ingredient formulations | |
WO2010087964A3 (en) | Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof | |
MX2010007011A (en) | Composition for human and/or animal nutrition, uses thereof and yeasts. | |
WO2011035335A3 (en) | Stabilized liquid and lyophilized adamts13 formulations | |
WO2010000877A3 (en) | Formulation with irritation reducing action comprising bisabolol and [6]-paradol | |
MY143795A (en) | Tetrahydropyridoindole derivatives | |
WO2010094009A3 (en) | Methods and compositions for the treatment of ras associated disorders | |
MX2010005159A (en) | Water dispersible enteric coating formulation for nutraceutical and pharmaceutical dosage forms. | |
WO2009055568A3 (en) | Liposomal vancomycin formulations | |
WO2008119943A3 (en) | Enteric pharmaceutical capsules | |
WO2011154905A3 (en) | Colored aqueous cosmetic compositions | |
WO2005094554A3 (en) | Therapeutic agents, methods, and treatments | |
MX2010005516A (en) | Compositions containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film-forming agent, methods for preparing same and uses thereof. | |
WO2011163467A3 (en) | Low-irritating, clear cleansing compositions with relatively low ph | |
WO2008113912A3 (en) | Novel cosmetic and/or pharmaceutical compositions and applications thereof | |
WO2007067519A3 (en) | The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions | |
MY179559A (en) | Cocoa powder compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980155742.9 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09836839 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011540971 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20117016274 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009836839 Country of ref document: EP |